Other OTC - Delayed Quote USD

Imagin Medical Inc. (IMEXF)

0.0059 0.0000 (0.00%)
At close: April 22 at 3:53 PM EDT
Loading Chart for IMEXF
DELL
  • Previous Close 0.0059
  • Open 0.0059
  • Bid --
  • Ask --
  • Day's Range 0.0059 - 0.0059
  • 52 Week Range 0.0059 - 0.1240
  • Volume 1,050
  • Avg. Volume 577
  • Market Cap (intraday) 118,905
  • Beta (5Y Monthly) 1.14
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Imagin Medical Inc., a urologic oncology company, focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers the i/Blue Imaging System, which detects bladder cancer with advanced proprietary optics and light sensors; and enCage Coil, a disposable and focal therapy precision ablation device for use in the treatment of prostate cancer. The company is also developing technologies to visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. It has a license agreement with Lawrence Livermore National Security, LLC to develop and commercialize the i/Blue Imaging System. The company was founded in 1986 and is headquartered in Vancouver, Canada.

imaginmedical.com

--

Full Time Employees

September 30

Fiscal Year Ends

Related News

Performance Overview: IMEXF

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

IMEXF
83.61%
S&P/TSX Composite index
4.42%

1-Year Return

IMEXF
94.64%
S&P/TSX Composite index
5.85%

3-Year Return

IMEXF
98.59%
S&P/TSX Composite index
14.57%

5-Year Return

IMEXF
99.54%
S&P/TSX Composite index
31.95%

Compare To: IMEXF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IMEXF

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    118.90k

  • Enterprise Value

    10.03M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    -13.45

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -191.49%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -3.32M

  • Diluted EPS (ttm)

    -0.2000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    22.17k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -241.69k

Company Insights: IMEXF

People Also Watch